[Epidemiological points of view on the response of enteropathogenic strains of E. coli to ampicillin, paromomycin, gentamycin, cephalothin and nalidixic acid].
D000667:Ampicillin / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002512:Cephalothin / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005839:Gentamicins / Q000494:pharmacology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009268:Nalidixic Acid / Q000494:pharmacology*; D010303:Paromomycin / Q000494:pharmacology*; D010403:Penicillin Resistance
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D009268:Nalidixic Acid; D010303:Paromomycin; D000667:Ampicillin; D002512:Cephalothin
Puncte de vedere epidemiologice privind comportarea tulpinilor enteropatogene de E. coli la ampicilină, paromomicină, gentamicină, cefalotină şi acid nalidixic.